Patents by Inventor Stephanie A. Broome

Stephanie A. Broome has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7585843
    Abstract: Compositions and methods are provided for the treatment or prevention of autoimmune disease. Therapeutic doses of one or more modified therapeutic ordered peptide(s) comprising amino acids representing a consensus sequence of a protein identified as a target of the autoimmune T and B cell response are described. Of particular interest are therapeutic ordered peptides of the autoantigens in multiple sclerosis, for example the myelin proteins MBP, MOG, PLP, MAG and cyclic nucleotide phosphodiesterase. The therapeutic ordered peptide may be extended at either termini by the addition of other D- or L- amino acid residues. The therapeutic ordered peptides may be administered topically or parenterally, by injection at a particular site, including subcutaneously, intraperitoneally, intravascularly, or the like or transdermally, as by electrotransport. The compositions of the invention may also contain other therapeutically active agents.
    Type: Grant
    Filed: October 1, 2004
    Date of Patent: September 8, 2009
    Assignee: Bayhill Therapeutics, Inc.
    Inventors: Hideki Garren, Stephanie Broome
  • Publication number: 20070275899
    Abstract: Compositions and methods are provided for the treatment of demyelinating autoimmune disease. Therapeutic doses are administered of a combination of therapeutic ordered peptides or one or more modified therapeutic ordered peptide(s) comprising amino acids representing a consensus sequence of a protein identified as a target of the autoimmune T and B cell response. Of particular interest are therapeutic ordered peptides of the target proteins in multiple sclerosis, for example the myelin proteins MBP, MOG, PLP, MAG and cyclic nucleotide phosphodiesterase The therapeutic ordered peptide may consist only of the ordered repeats, or may be extended at either termini by the addition of other D- or L-amino acid residues. For therapy, the therapeutic ordered peptides may be administered topically or parenterally, by injection at a particular site, including subcutaneously, intraperitoneally, intravascularly, or the like or transdermally, as by electrotransport.
    Type: Application
    Filed: October 1, 2004
    Publication date: November 29, 2007
    Applicant: Bayhill Therapeutics, Inc.
    Inventors: Hideki Garren, Stephanie Broome
  • Patent number: 4565785
    Abstract: A plasmid or phage gene for a periplasmic or extracellular bacterial protein is cleaved, a double-stranded DNA sequence coding for a selected protein or portion thereof from a eukaryotic cell such as insulin is inserted in that cleaved gene by recombinant DNA techniques and used to transform a bacterium, and the excreted selected protein is collected.
    Type: Grant
    Filed: August 1, 1983
    Date of Patent: January 21, 1986
    Assignee: The President and Fellows of Harvard College
    Inventors: Walter Gilbert, Stephanie A. Broome, Lydia J. Villa-Komaroff, Argiris A. Efstratiadis
  • Patent number: 4411994
    Abstract: A plasmid or phage gene for a periplasmic or extracellular bacterial protein is cleaved, a double-stranded DNA sequence coding for a selected protein or portion thereof from a eukaryotic cell such as insulin is inserted in that cleaved gene by recombinant DNA techniques and used to transform a bacterium, and the excreted selected protein is collected.
    Type: Grant
    Filed: June 8, 1978
    Date of Patent: October 25, 1983
    Assignee: The President and Fellows of Harvard College
    Inventors: Walter Gilbert, Stephanie A. Broome, Lydia J. Villa-Komaroff, Argiris A. Efstratiadis